Advertisement

Topics

Merck’s Pneumococcal Vaccine for Babies Looks Good in Trial

20:00 EDT 8 May 2019 | BioSpace

Merck and Co. announced that its investigational 15-valent pneumococcal conjugate vaccine was “noninferior” to a currently available 13-valent pneumococcal conjugate vaccine in healthy babies 6 to 12 weeks of age.

Original Article: Merck’s Pneumococcal Vaccine for Babies Looks Good in Trial

NEXT ARTICLE

More From BioPortfolio on "Merck’s Pneumococcal Vaccine for Babies Looks Good in Trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...